SIERRA ONCOLOGY, INC.
c/o 2150 – 885 West Georgia Street
Vancouver, British Columbia, Canada V6C 3E8
June 19, 2018
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
| Attention: | Abigail Jacobs |
Mary Beth Breslin
Re: Sierra Oncology, Inc. Registration Statement on Form S-3
Filed June 15, 2018 (File No. 333- 225650)
Requested Date: June 21, 2018
Requested Time: 4:30 p.m. Eastern Time
Ladies and Gentlemen:
Sierra Oncology, Inc. (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to make the above-captioned Registration Statement on Form S-3 effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable.
The Registrant hereby authorizes Robert Freedman or Amanda Rose, both of whom are attorneys with the Registrant’s outside legal counsel, Fenwick & West LLP, to orally modify or withdraw this request for acceleration.
The Registrant requests that it be notified of such effectiveness by a telephone call to Ms. Rose at (206) 389-4553, or in her absence, Mr. Freedman at (650) 335-7292.
| Sincerely, | ||
| SIERRA ONCOLOGY, INC. | ||
| By: | /s/ Sukhi Jagpal | |
| Sukhi Jagpal | ||
| Chief Financial Officer | ||
